Director · Connect Biopharma Holdings Ltd · Ordinary Shares
Side
A
Value
—
Shares
2,816
Price
—
Executed
Mar 31, 2026
Disclosed
Apr 2, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Mar 31 executedApr 2, 2026 disclosed
CNTB · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · 3.5% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Xanthopoulos Kleanthis Gabriel filed this Form 4 reporting a grant or award of CNTB on Mar 31, 2026. It became public on Apr 2, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Xanthopoulos Kleanthis Gabrielcik:0002115875
Issuer
Connect Biopharma Holdings Ltdcik:0001835268
Revision history · 0
No field has changed since this record was first ingested.
